Skip to content

Effect of preemptive duloxetine for postoperative pain

Effect of preemptive duloxetine for postoperative pain - Duloxetine for postoperative pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031428
Enrollment
66
Registered
2018-04-11
Start date
2018-05-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain

Interventions

Duloxetine (40 mg) will be orally administered 2h before surgery, then postoperative pain will be assessed. Diazepam (4 mg) will be orally administered 2h before surgery as active placebo group.

Sponsors

Fukushima Medical University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled to undergo posterior lumbar interbody fusion will be enrolled in this study. The study population included patients aged 20-80 years who are American Society of Anesthesiologists physical status I-II and who agreed to participate in this clinical trial.

Exclusion criteria

Exclusion criteria: 1) Patients who can not use duloxetine 2) Patients who need antipsychotics or antidepressants and who are schizophrenia, bipolar disease, or depression within a year before registration of this study. 3) Patients who needs opioids 4) Patinets who can not agree the protocol.

Design outcomes

Primary

MeasureTime frame
Postoperative pain using visual analogue scale

Secondary

MeasureTime frame
Consumption of postoperative analgesics

Countries

Japan

Contacts

Public ContactHideaki Obata

Fukushima Medical University Hospital Center for Pain Management

obata@fmu.ac.jp024-547-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026